Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics is a clinical-stage biotech company focused on developing novel immunotherapies for cancer treatment. Their unique approach leverages the body's innate immune system to target and destroy cancer cells, offering a personalized and potentially more effective alternative to traditional therapies. Bolt's flagship technology, the Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) platform, utilizes tumor-targeting antibodies to activate the innate immune response, creating a durable anti-cancer effect.

Bolt Biotherapeutics is based in the San Francisco Bay Area and has a highly experienced management team with expertise in immuno-oncology drug discovery, development, and commercialization. Their pipeline includes several promising candidates, including BDC-3042, a first-in-class Dectin-2 agonist antibody, and BDC-4182, a next-generation ISAC targeting Claudin 18.2. Bolt is committed to generating breakthroughs for patients in need of new treatment options while maintaining the best quality of life possible.

Bolt Biotherapeutics offers employees significant flexibility in their work arrangements. They provide the equipment needed for effective work from home, along with flexible hours for all employees, including those in laboratory roles. This emphasis on work-life balance is further underscored by their generous time off policy, including three weeks of paid vacation per year with separate sick time benefits, and coverage for telecom expenses like home internet and cell phone plans.

Bolt Biotherapeutics offers a comprehensive benefits package designed to support employee well-being and work-life balance. This includes 100% paid health insurance premiums for employees and their families, with a wide selection of plans available. The company promotes flexible work arrangements with work-from-home options and flexible hours for all employees, even those in the lab. Employees are eligible for a competitive compensation program with equity and bonus plans. Bolt also provides three weeks of paid vacation per year, separate sick time benefits, and a monthly stipend for home internet and cell phone expenses. Additionally, they offer support for working parents with access to online camps and educational resources for children.

Bolt Biotherapeutics is a clinical-stage biopharmaceutical company dedicated to finding better ways to treat cancer by leveraging the power of the immune system. Their innovative approach focuses on using the innate immune system to recognize and kill cancer cells, working with the body’s natural defenses rather than against them. They are pioneering new immunotherapies using myeloid cells and the innate immune system to create targeted treatments that can also activate the adaptive immune system, ultimately aiming to generate breakthroughs for patients in need of new treatment options.

Bolt Biotherapeutics fosters a culture of innovation and collaboration, valuing fearless risk-taking, rigorous research, and open-mindedness. They encourage their employees to be tenacious, ethical, daring, and thoughtful while embracing iterative learning in a solution-oriented environment. Bolt Biotherapeutics values its employees and promotes individuality through autonomy and respect, creating a supportive and engaging work environment.

Bolt Biotherapeutics is committed to fostering a diverse, equitable, and inclusive workplace where everyone feels valued, respected, and empowered to contribute their unique talents and perspectives. They prioritize building a culture that celebrates diversity in thought, background, and experience, recognizing that this leads to better decision-making, innovation, and patient outcomes. Bolt strives to create an environment where all employees feel a sense of belonging, where they can reach their full potential, and where they can contribute to the company's mission of finding better ways to treat cancer.